Collagen production in cardiac fibroblasts during inhibition of aminopeptidase B

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 6, Issue 2, 2005, Pages 69-77

  Lijnen, Paul J ^a,b   Petrov, Victor V ^a   Turner, Marisa ^a   Fagard, Robert H ^a  

^a KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Aminopeptidase B; Cardiac fibroblasts; Collagen production

Indexed keywords

3 AMINOPROPIONITRILE; 4 NITROANILINE; ALANINE; AMINOPEPTIDASE B; ARGININE; ARPHAMENINE A; ASCORBIC ACID; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GELATINASE A; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PROLINE; PROTEIN LYSINE 6 OXIDASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DATA ANALYSIS; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; FIBROBLAST; FIBROBLAST CULTURE; HEART MUSCLE CELL; INCUBATION TIME; MALE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY;

EID: 28244448588     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2005.012     Document Type: Article

References (44)

1. Petrov V, Fagard R, Lijnen R Transforming growth factor-beta1 induces angiotensin converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts. JRAAS 2000;1:342-52.
2. Petrov V, Fagard R, Lijnen P. Stimulation of collagen production by transforming growth factor-β1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 2002;39:258-63.
3. Lijnen P, Petrov V, Fagard R. Transforming growth factor β1-mediated collagen gel contraction by cardiac fibroblasts. JRAAS 2003;4:113-18.
4. Petrov V, Fagard R, Lijnen P. Induction of various aminopeptidases in cardiac fibroblasts by transforming growth factor-beta1. J Hypertension 2003;21:S239.
5. Petrov V, Fagard R, Lijnen P. Arginine-aminopeptidase in rat cardiac fibroblastic cells participates in angiotensin peptide turnover. Cardiovasc Res 2004;61:724-35.
6. Lijnen P, Fagard R, Lijnen P. Collagen production in cardiac fibroblasts during inhibition of angiotensin converting enzyme and aminopeptidases. J Hypertension 2004;22:209-16.
7. Lijnen P, Petrov V, Fagard R. Reversal of angiotensin II-stimulated collagen gel contraction in cardiac fibroblasts by aminopeptidase-inhibition. Am J Cardiovasc Pharmacol 2005;45:68-73.
8. Lijnen P, Petrov V, Fagard R. Effect of bestatin on angiotensin I-, II- and III-induced stimulation of collagen gel contraction in cardiac fibroblasts. JRAAS 2004;5:183-8.
9. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts. Respone to angiotensin II and aldosterone. J Mol Cell Cardiol 1994;26:809-20.
10. De Young MB, Giannattasio B, Scarpa A. Isolation of calcium-tolerant atrial and ventricular myocytes from adult rat heart. In: Biomembranes, Fleischer S & Fleischer B, eds, Academic Press, 1989; pp. 662-76.
11. Peterkofski B. Estimation of total collagen production by collagenase digestion. In: Extracellular Matrix, Haralson MA & Hassell JR, eds., Oxford University Press, 1995; pp. 31-8.
12. Köhler E, Bertschin S, Woodtli T, Resink T, Erne P. Does aldosterone-induced cardiac fibrosis involve direct effects on cardiac fibroblasts? J Vasc Res 1996;33:315-26.
13. Downs TR, Wilfinger WW. Fluorimetric quantification of DNA in cells and tissue. Anal Biochem 1983;131:538-47.
14. Palamakumbura AH, Trackman PC. A fluorimetric assay for detection of lysyl oxidase enzyme activity in biological samples. Anal Biochem 2002;300:245-51.
15. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-9.
16. Chomzynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-7.
17. Nakagawa S, Pawelek P, Grinell F. Extracellular matrix organization modulates growth and growth factor responsiveness. Exper Cell Res 1989;182:572-82.
18. Kagan HM, Li W. Lysyl oxidase: Properties, specificity and biological role inside and outside the cell. J Cell Biochem 2003;88:660-72.
19. Smith-Mungo L, Kagan H, Lysyl oxidase: Properties, regulation and multiple function in biology. Matrix Biol 1998;16:387-98.
20. Kagan HM. Characterization and regulation of lysyl oxidase. In "Biology of extracellular matrix: A Series. Regulation of matrix accumulation" Vol. 1 RP Mecham, ed., Acad. Press, Orlando, 1986, pp. 321-98.
21. Tsuda T, Gao E, Evangelista L, Markova D, Ma X, Chu ML. Post-ischemic myocardial fibrosis occurs independent of hemodynamic changes. Cardiovasc Res 2003;59:926-33.
22. McCormick RJ, Musch TJ, Bergman BC, Thomas DP, Regional differences in LV collagen accumulation and mature cross-linking after myocardial infarction in rats. Am J Physiol 1994;266:H354-9.
23. Kato S, Spinale R, Tanaka R, Johnson W, Cooper G, Zile MR. Inhibition of collagen cross-linking: effects on fibrillar collagen and ventricular diastolic function. Am J Physiol 1995;269:H863-8.
24. Norton GR, Tsotetsi J, Trifunovic B, Hartford C, Candy GP, Woodiwiss AJ. Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats. Circulation 1997;96: 1991-8.
25. Badenhorst D, Maseko M, Tsotetsi OJ et al. Cross-linking influences the impact of quantitative changes in myocardial collagen on cardiac stiffness and remodeling in hypertension in rats. Cardiovasc Res 2003;57:632-41.
26. Koshy SKG, Reddy HK, Shukla HH. Collagen cross-linking: a new dimension to cardiac remodeling. Cardiovasc Res 2003;57:594-8.
27. Woodiwiss AJ, Tsotetsi OJ, Sprott S et al. Reduction in myocardial collagen cross-linking parallels ventricular dilatation in rat models of systolic chamber dysfunction. Circulation 2001;103:155-60.
28. Strauss BH, Robinson R, Batchelor WB et al. In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases. Circ Res 1996;79:541-50.
29. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994;75:650-8.
30. Sluijter JPG, Smeets MB, Velema E, Pasterkamp G, de Kleijn DPV. Increased collagen turnover is only partly associated with collagen fiber deposition in the arterial response to injury. Cardiovasc Res 2004;61:186-95.
31. Spinale FG. Matrix metalloproteinases. Regulation and dysregulation in the failing heart. Circ Res 2002;90:520-30.
32. Tyagi SC, Kumar SG, Alla SR, Reddy HK, Voelker DJ, Janicki JS. Extracellular matrix regulation of metalloproteinase and antiproteinase in human heart fibroblasts. J Cell Physiol 1996;167:137-47.
33. Tyagi SC, Campbell SE, Reddy HK, Tjahja E, Voelker DJ. Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Mol Cell Biochem 1996;155:13-21.
34. Tyagi SC, Kumar S, Voelker DJ, Reddy HK, Janicki JS, Curtis JJ. Differential gene expression of extracellular matrix components in dilated cardiomyopathy. J Cell Biochem 1996;63:185-98.
35. Capasso JM, Robinson TF, Anversa P. Alterations in collagen cross-linking impair myocardial contractility in the mouse heart. Circ Res 1989;65:1657-64.
36. Gunja-Smith Z, Morales AR, Romanelli R, Woessner J Jr. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinasess and pyridinoline cross-links. J Pathol 1996;148:1639-48.
37. Spinale FG, Zellner JL, Johnson WS, Eble DM, Munyer PL. Cellular and extracellular remodeling with the development and recovery from tachycardia-induced cardiomyopathy: changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans. J Mol Cell Cardiol 1996;28:1591-608.
38. Burgess ML, Carver WE, Terracio L, Wilson SP, Borg TK. Integrin-mediated collagen gel contraction by cardiac fibroblasts. Circ Res 1994;74:291-8.
39. Watson S, Burnside T, Carver W. Angiotensin II-stimulated collagen gel contraction hy heart fibroblasts. Role of the AT1-receptor and tyrosine kinase activity. J Cell Physiol 1998;177: 224-31.
40. Aoyagi T, Wada T, Kojima F et al. Inhibitors of aminopeptidase B suppress the development of hypertension in spontaneously hypertensive rats. Chem Pharm Biol 1986;34:4852-4.
41. Kitamura S, Carbini LA, Simmons WH, Scicli AG. Effects of aminopeptidase P inhibition on kinin-mediated vasopressor responses. Am J Physiol 1999;276:H1664-71.
42. Dzoljic E, Varagic VM. Effects of bestatin and phosphoramidon on the hypertensive response to physostigmine in the rat. Fundam Clin Pharmacol 1987;1:307-16.
43. Jensen LL, Harding JW, Wright JW. Increased blood pressure induced by central application of aminopeptidase inhibitors is angiotensinergic-dependent in normotensive and hypertensive rat strains. Brain Res 1989;490:48-53.
44. Reaux A, Fournie-Zaluski MC, David C et al. Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci USA 1999;96:13415-20.